This aligns with previous findings associating HNF4A knockdown with an upregulation of WNT pathway signaling molecules, and HNF4A loss drives metabolic reprogramming at an early stage of pancreatic cancer progression10. This evidence concerns the gene HNF4A and familial pancreatic carcinoma.